CG
WST icon

Cutler Group’s West Pharmaceutical WST Stock Holding History

Cutler Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-68
Closed -$6K – 6081
2017
Q3 		$6K Sell
68
-2,482
-97% -$225K ﹤0.01% 4274
2017
Q2 		$241K Buy
2,550
+2,412
+1,748% +$222K 0.01% 1144
2017
Q1 		$11K Buy
+138
New +$11.5K ﹤0.01% 3967
2016
Q3 		– Sell
-421
Closed -$33.4K – 7481
2016
Q2 		$31K Buy
421
+221
+111% +$16.1K ﹤0.01% 2884
2016
Q1 		$13K Sell
200
-100
-33% -$6.02K ﹤0.01% 3780
2015
Q4 		$18K Buy
+300
New +$18K ﹤0.01% 3530

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Cutler Group's WST Position: Q4 2017 in Review

Cutler Group sold out of West Pharmaceutical (WST) in Q4 2017, closing a stake of 68 shares — an estimated $6K sold.

Cutler Group first reported a position in WST in Q4 2015 and held it in 6 quarters. The position peaked at $241K in Q2 2017. 338 funds tracked by Wall St. Rank hold WST as of Q4 2017.

  • Cutler Group reported no remaining West Pharmaceutical position as of Q4 2017 after selling out during the quarter.
  • Cutler Group sold 68 West Pharmaceutical shares in Q4 2017, an estimated $6K.
  • Cutler Group first reported a position in West Pharmaceutical in Q4 2015 and held it in 6 quarters.
  • Cutler Group's West Pharmaceutical position peaked at $241K in Q2 2017.
  • 338 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2017.

Based on Cutler Group's 13F filing for Q4 2017, filed 17 Jan 2018.